MedTrace Logo

Muscle Inflammation and Fat Infiltration in Patients Affected by FSHD

NCT02541292 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2018-09-04

No results posted yet for this study

Summary

Facioscapulohumeral muscular dystrophy (FSHD) is the second most common muscular dystrophy with approximately 500 patients in Denmark. It is characterized by weakness and wasting of the facial muscles, the muscles in the shoulder region and of the legs.

The primary aim of this study is to investigate possible links and order between inflammation and fat infiltration in the muscles in patients with FSHD.

Approximately 15 patients with FSHD will be recruited for repeated MRI-scans during a year where the inflammation and fat infiltration in the muscles can be quantified.

Conditions

  • Facioscapulohumeral Muscular Dystrophy 1a

Interventions

OTHER

No intervention, observational

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2018-11-30
Completion
2018-11-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02541292 on ClinicalTrials.gov